Dr Agarwal's Health Care Raises Rs 875.5 cr Ahead of IPO
By Rediff Money Desk, New Delhi Jan 28, 2025 22:01
Dr Agarwal's Health Care, an eye care services provider, has raised over Rs 875.5 crore from anchor investors ahead of its initial public offering (IPO). The IPO will open for subscription from January 29 to January 31.
New Delhi, Jan 28 (PTI) Temasek Holdings and TPG-backed Dr Agarwal's Health Care, an eye care services provider, on Tuesday said it has raised over Rs 875.5 crore from anchor investors ahead of its initial public offering (IPO).
The Government of Singapore, Monetary Authority of Singapore, Goldman Sachs, Morgan Stanley, Government Pension Fund Global (Norway), Fidelity, Nomura, Invesco Mutual Fund (MF), Motilal Oswal MF, Canara Robeco MF and Tata MF are among the anchor investors, according to a circular uploaded on BSE's website.
As per the circular, the company has allotted 2.17 crore equity shares to 43 funds at Rs 402 apiece, which is also the upper end of the price band.
This aggregates the transaction size to Rs 875.50 crore.
Of the total allocation of 2.17 crore equity shares to anchor investors, 52.61 lakh shares were allocated to 6 domestic mutual funds, which have applied through a total of their 11 schemes.
The Rs 3,027.26-crore public issue, with a price band of Rs 382 to Rs 402 per share, will be open for subscription from January 29 to January 31.
The IPO is a combination of a fresh issue of up to Rs 300 crore and an Offer For Sale (OFS) of up to 6.78 crore equity shares worth Rs 2,727.26 crore by promoters and other selling shareholders at the upper end of the price band.
The offer also includes a subscription for eligible employees.
Those selling shares in the OFS include Arvon Investments Pte Ltd, Claymore Investments (Mauritius) Pte Ltd, and Hyperion Investments Pte Ltd.
Proceeds from the fresh issue to the tune of Rs 195 crore will be used for payment of debt, and besides, a portion will be used for general corporate purposes and unidentified inorganic acquisitions.
Half of the issue size has been reserved for qualified institutional buyers, 35 per cent for non-institutional investors and the remaining 15 per cent for retail investors.
Dr Agarwal's Health Care offers a wide array of services, including cataract, refractive, and other surgeries, consultations, diagnosis, non-surgical treatments, and the sale of optical products, contact lenses, accessories, and eye care-related pharmaceutical items.
As of September 2024, its network consisted of 193 facilities with a majority concentration in South India, particularly Chennai, Hyderabad and Bengaluru, followed by Western India.
On the financial front, Dr Agarwal's Health Care revenue from operations was Rs 1,332.15 crore in the fiscal 2024 and profit after tax stood at Rs 95.05 crore.
Kotak Mahindra Capital Company, Morgan Stanley India Company, Jefferies India and Motilal Oswal Investment Advisors are the book-running lead managers to the issue.
The Government of Singapore, Monetary Authority of Singapore, Goldman Sachs, Morgan Stanley, Government Pension Fund Global (Norway), Fidelity, Nomura, Invesco Mutual Fund (MF), Motilal Oswal MF, Canara Robeco MF and Tata MF are among the anchor investors, according to a circular uploaded on BSE's website.
As per the circular, the company has allotted 2.17 crore equity shares to 43 funds at Rs 402 apiece, which is also the upper end of the price band.
This aggregates the transaction size to Rs 875.50 crore.
Of the total allocation of 2.17 crore equity shares to anchor investors, 52.61 lakh shares were allocated to 6 domestic mutual funds, which have applied through a total of their 11 schemes.
The Rs 3,027.26-crore public issue, with a price band of Rs 382 to Rs 402 per share, will be open for subscription from January 29 to January 31.
The IPO is a combination of a fresh issue of up to Rs 300 crore and an Offer For Sale (OFS) of up to 6.78 crore equity shares worth Rs 2,727.26 crore by promoters and other selling shareholders at the upper end of the price band.
The offer also includes a subscription for eligible employees.
Those selling shares in the OFS include Arvon Investments Pte Ltd, Claymore Investments (Mauritius) Pte Ltd, and Hyperion Investments Pte Ltd.
Proceeds from the fresh issue to the tune of Rs 195 crore will be used for payment of debt, and besides, a portion will be used for general corporate purposes and unidentified inorganic acquisitions.
Half of the issue size has been reserved for qualified institutional buyers, 35 per cent for non-institutional investors and the remaining 15 per cent for retail investors.
Dr Agarwal's Health Care offers a wide array of services, including cataract, refractive, and other surgeries, consultations, diagnosis, non-surgical treatments, and the sale of optical products, contact lenses, accessories, and eye care-related pharmaceutical items.
As of September 2024, its network consisted of 193 facilities with a majority concentration in South India, particularly Chennai, Hyderabad and Bengaluru, followed by Western India.
On the financial front, Dr Agarwal's Health Care revenue from operations was Rs 1,332.15 crore in the fiscal 2024 and profit after tax stood at Rs 95.05 crore.
Kotak Mahindra Capital Company, Morgan Stanley India Company, Jefferies India and Motilal Oswal Investment Advisors are the book-running lead managers to the issue.
Source: PTI
Read More On:
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- NHC Foods
- 1.13 ( -4.24)
- 43232893
- Vodafone Idea L
- 9.00 (+ 0.67)
- 32047620
- Murae Organisor
- 2.06 (+ 4.57)
- 15008514
- Spicejet Ltd.
- 49.61 (+ 5.71)
- 10223192
- YES Bank Ltd.
- 18.96 (+ 0.80)
- 9887245
MORE NEWS
Texmaco, Hines, Conscient, HDFC Partner for...
Texmaco Infrastructure partners with Hines, Conscient, and HDFC Capital to develop a...
Brookfield REIT Q3 NOI Rises 11% to Rs 503.7 cr
Brookfield India Real Estate Trust reports 11% increase in adjusted net operating...
Trump Tariff Threat Concerns Exporters in India
Exporters raised concerns with India's Commerce Minister Piyush Goyal about US...